Skip to main content

Abrysvo

Product overview

Vaccine type
Respiratory Syncytical Virus vaccine
Commercial Name
Abrysvo
Manufacturer
Pfizer Europe MA EEIG
Manufacturer Country
Belgium
Responsible NRA
European Medicines Agency
Country
Netherlands

Prequalification

Effective Date

Product description

Pharmaceutical Form
Lyophilised active component to be reconstituted with excipient diluent before use
Presentation
Two vial set (active + excipient)
Number of Doses
1
Diluent
Water for Injection
Route of Administration
Intramuscular
Shelf Life
30 months
Storage Temperature
2-8°C
Vaccine Vial Monitor
Type 30
Secondary Packaging
Vaccine and diluent are packed separatetly in a box of 25 vials (25 doses) each. Dimensions: 8.6 x 8.6 x 4.1 cm. Diluent should be stored below 30°C.
Tertiary Packaging
Vaccine and diluent are packed separatetly in a shipping box containing 40 cartons of 25 vials (1000 vials/1000 doses) each. Dimensions 39.5 x 19 x 23.2 cm.
Multidose Vial Policy
Not Applicable
Vaccine Preservative
none
Cold Chain Volume
12.1 cm3/dose (in secondary packaging)

Attachments

Package Insert